Skip to main content
Clinical Trials/ACTRN12616001355460
ACTRN12616001355460
Terminated
Phase 3

A randomised controlled clinical trial to evaluate the effectiveness and safety of combining varenicline with nicotine e-cigarettes on smoking abstinence in people with co-existing mental health and drug and alcohol dependence conditions.

The University of Auckland0 sites15 target enrollmentSeptember 29, 2016

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Smoking
Sponsor
The University of Auckland
Enrollment
15
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2016
End Date
March 15, 2019
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \*currently live in the Auckland region
  • \*are registered clients with Community Mental Health Services or Community Alcohol and Drug Services
  • \*smoke cigarettes daily
  • \*want to quit smoking
  • \*are at least 18 years of age
  • \*are able to provide written informed consent
  • \*have access to a telephone (mobile and/or landline)
  • \*are prepared to use varenicline alone or with e\-cigarettes
  • \*have tried to quit at least twice before with nicotine replacement therapy (NRT), and thus are eligible for special authority varenicline

Exclusion Criteria

  • \*are pregnant or breastfeeding.
  • \*are current users of other smoking cessation medications.
  • \*are enrolled in a smoking cessation programme or another cessation research study.
  • \*have used an e\-cigarette for more than one week in the last year for smoking cessation.
  • \*have contraindications for varenicline or nicotine e\-cigarettes.
  • \*another person in their household is already in the trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A clinical study to compare effect of kushmand choornavati with Tagar ghanvati as anxiolytic and sedative as pre-medication in spinal anaesthesiaHealth Condition 1: F409- Phobic anxiety disorder, unspecified
CTRI/2020/01/022835PDEAS College of Ayurved and research centre
Not yet recruiting
Not Applicable
A clinical trial to study the effects of two procedures, shatpushpa siddha taila nasya and shatpushpa siddha taila matrabasti in patients with irregular menses and pcos.Health Condition 1: E282- Polycystic ovarian syndrome
CTRI/2024/03/063784Chaitalee Rajendra Jain
Recruiting
Phase 2
A trial examining the use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for children undergoing microlaryngoscopy and bronchoscopyRespiratory diseaseAnaesthesiology - AnaestheticsRespiratory - Other respiratory disorders / diseases
ACTRN12617000799358Auckland District Health Board250
Completed
Not Applicable
A randomised controlled clinical trial to evaluate the anti-osteolytic agent clodronate for the prevention of the development of bone metastases in patients with primary breast cancer
ISRCTN83688026Royal Marsden Hospital (UK), secondary sponsor Schering (Germany)1,000
Completed
Not Applicable
High dose fluconazole with or without flucytosine in the treatment of human immunodeficiency virus (HIV)-associated cryptococcal meningitiscryptococcal meningitisCryptococcal meningitis/ HIVInfections and InfestationsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
ISRCTN02725351St George's University of London (UK)80